Xbrane Biopharma: A new beginning? - Redeye
Bildkälla: Stockfoto

Xbrane Biopharma: A new beginning? - Redeye

Redeye provides an update on Xbrane following the recent deal with Alvotech, which has materially improved the company’s financial position, prompting positive revisions to our valuation model.

Redeye provides an update on Xbrane following the recent deal with Alvotech, which has materially improved the company’s financial position, prompting positive revisions to our valuation model.
Börsvärldens nyhetsbrev